LifeMD, Inc.
SEC EDGAR quarterly and annual company filings
Past bets that played out
These are the clearest thesis calls with observable outcomes, linked back to the original videos.
The provided 10‑Q text is only the cover page/header (issuer identity, exchange listing, and registered securities) and does not include financial statements, MD&A, risk factors, guidance, liquidity discussion, or any operational updates. As a result, there is no substantive incremental information to form a bullish/bearish thesis or a trade with a defensible direction.
Cover page of LifeMD, Inc. (LFMD) FY2025 10-K (period ended 2025-12-31). No financial statements, guidance, risk-factor changes, or MD&A details provided in the excerpt, so actionable trading signals are limited. Identified listed securities: LFMD common and LFMDP preferred on Nasdaq Global Market.
Cover page of LifeMD, Inc. (LFMD) FY2025 10-K (period ended 2025-12-31). No financial statements, guidance, risk-factor changes, or MD&A details provided in the excerpt, so actionable trading signals are limited. Identified listed securities: LFMD common and LFMDP preferred on Nasdaq Global Market.
What this channel is watching now
Recent mentions show where this author is concentrating attention right now.
Latest videos and market context
Recent source posts from this author. Create an account to inspect the complete persisted research trail.
GEV 10-Q report for 2026-06-30
The provided excerpt is only the Form 10‑Q cover page for GE Vernova Inc. (GEV) for quarter ended 2026‑06‑30, with no financial statements, MD&A, segment results, guidance, backlog, risks, or other performance details included. As-is, it contains almost no trade-relevant incremental information beyond confirming the filing/period and listing details.
SNBR 10-Q report for 2026-04-04
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
SOUN 10-Q report for 2026-03-31
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
WEAT 10-Q report for 2026-03-31
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
Proof-backed call history
These are recent thesis calls tied to original source content where available.
The provided 10‑Q text is only the cover page/header (issuer identity, exchange listing, and registered securities) and does not include financial statements, MD&A, risk factors, guidance, liquidity discussion, or any operational updates. As a result, there is no substantive incremental information to form a bullish/bearish thesis or a trade with a defensible direction.
Cover page of LifeMD, Inc. (LFMD) FY2025 10-K (period ended 2025-12-31). No financial statements, guidance, risk-factor changes, or MD&A details provided in the excerpt, so actionable trading signals are limited. Identified listed securities: LFMD common and LFMDP preferred on Nasdaq Global Market.
Cover page of LifeMD, Inc. (LFMD) FY2025 10-K (period ended 2025-12-31). No financial statements, guidance, risk-factor changes, or MD&A details provided in the excerpt, so actionable trading signals are limited. Identified listed securities: LFMD common and LFMDP preferred on Nasdaq Global Market.
The provided excerpt is only the cover/page header of LifeMD, Inc.’s Form 10‑Q for the quarter ended 2025‑09‑30. It identifies the registrant, exchange listing, and the two Nasdaq-traded securities (LFMD common and LFMDP preferred), but contains no financial statements, MD&A, guidance, risk updates, liquidity disclosures, or operational metrics. As-is, it is not sufficient to form an evidence-based bullish/bearish view from the filing content.
Excerpt is only the cover/header of LifeMD, Inc. (LFMD) Form 10-Q for quarter ended 2025-06-30. It confirms ticker/listings (LFMD common; LFMDP 8.875% Series A cumulative perpetual preferred) and that the company is current on SEC filing requirements. No financial statements, KPIs, guidance, risk-factor updates, or MD&A content provided, so investable conclusions are limited.
Excerpt is only the cover/header of LifeMD, Inc. (LFMD) Form 10-Q for quarter ended 2025-06-30. It confirms ticker/listings (LFMD common; LFMDP 8.875% Series A cumulative perpetual preferred) and that the company is current on SEC filing requirements. No financial statements, KPIs, guidance, risk-factor updates, or MD&A content provided, so investable conclusions are limited.
About this channel
Channel bio, source link, and public-market context from YouTube.
SEC EDGAR quarterly and annual company filings
Most recognized assets
Unlock the full track record
Create an account to inspect the complete author history, trust-weighted rankings, and persisted research across authors, theses, and assets.